Skeletal muscle precursor cells (MPCs) are considered key candidates for cell therapy in the treatment of skeletal muscle dysfunction due to injury, disease, or aging. However, expansion of a sufficient number of functional skeletal muscle cells in vitro from a small tissue biopsy has been challenging due to changes in the phenotypic expression of these cells under nonnatural microenvironmental or traditional culture conditions. This review provides an overview of recent progress in the design and biofabrication of advanced tissue-specific extracellular matrix (ECM) proteins for use in the enhancement of expansion and differentiation of MPCs for cell therapy and 3D bioprinting. We start with a brief introduction about the existing progress, drawbacks, and emerging challenges in the culture and maintenance of long term primary human MPCs for cell therapy. With regard to MPC proliferation, elongation, fusion, and differentiation into mature myofibers, we systematically summarize the benefits and limitations of recent progress. The importance of tissue-specific ECM in skeletal muscle regeneration is discussed, in particular, the mechanisms, rationale, strategy, and methodologies for using tissue-specific ECM proteins for myogenesis in 2D and 3D culture environments. Furthermore, perspectives on the challenges in developing tissue-specific ECM proteins for cell therapy using human MPCs are described. Finally, we propose potential strategies for overcoming the challenges in the development of advanced tissue-specific ECM proteins for promoting cell therapy with human skeletal muscle cells.
References
1.
D. C.
Zebrowski
, S.
Vergarajauregui
, C.-C.
Wu
, T.
Piatkowski
, R.
Becker
, M.
Leone
et al, “Developmental alterations in centrosome integrity contribute to the post-mitotic state of mammalian cardiomyocytes
,” Elife
4
, e05563
(2015
).2.
F. S.
Tedesco
, A.
Dellavalle
, J.
Diaz-Manera
, G.
Messina
, and G.
Cossu
, “Repairing skeletal muscle: Regenerative potential of skeletal muscle stem cells
,” J. Clin. Invest.
120
(1
), 11
–19
(2010
).3.
A. D.
Theocharis
, S. S.
Skandalis
, C.
Gialeli
, and N. K.
Karamanos
, “Extracellular matrix structure
,” Adv. Drug Delivery Rev.
97
, 4
–27
(2016
).4.
U.
Kuhl
, M.
Ocalan
, R.
Timpl
, and K.
von der Mark
, “Role of laminin and fibronectin in selecting myogenic versus fibrogenic cells from skeletal muscle cells in vitro
,” Dev. Biol.
117
(2
), 628
–635
(1986
).5.
M. E.
Danoviz
and Z.
Yablonka-Reuveni
, “Skeletal muscle satellite cells: Background and methods for isolation and analysis in a primary culture system
,” Methods Mol. Biol.
798
, 21
–52
(2012
).6.
C.
Hoffmann
and C.
Weigert
, “Skeletal muscle as an endocrine organ: The role of myokines in exercise adaptations
,” Cold Spring Harbor Perspect. Med.
7
(11
), a029793
(2017
).7.
E. H.
Marieb
and K. S.
Francisco
, Human Anatomy & Physiology
, 8th ed. (Benjamin Cummings
, 2010
), p. 312
, ISBN 978-0-8053-9569-3.8.
D.
Schumacher
, B. K.
Tischer
, J. P.
Teifke
, K.
Wink
, and N.
Osterrieder
, “Generation of a permanent cell line that supports efficient growth of Marek's disease virus (MDV) by constitutive expression of MDV glycoprotein E
,” J. Gen. Virol.
83
(Pt 8
), 1987
–1992
(2002
).9.
F.
Relaix
, D.
Rocancourt
, A.
Mansouri
, and M.
Buckingham
, “A Pax3/Pax7-dependent population of skeletal muscle progenitor cells
,” Nature
435
(7044
), 948
–953
(2005
).10.
E.
Brandan
and J.
Gutierrez
, “Role of skeletal muscle proteoglycans during myogenesis
,” Matrix Biol.
32
(6
), 289
–297
(2013
).11.
B. C.
Syverud
, J. D.
Lee
, K. W.
VanDusen
, and L. M.
Larkin
, “Isolation and purification of satellite cells for skeletal muscle tissue engineering
,” J. Regener. Med.
3
(2
), 117
(2014
).12.
M.
Sampaolesi
, S.
Blot
, G.
D'Antona
, N.
Granger
, R.
Tonlorenzi
, A.
Innocenzi
et al, “Corrigendum: Mesoangioblast stem cells ameliorate muscle function in dystrophic dogs
,” Nature
494
(7438
), 506
(2013
).13.
H.
Chang
, M.
Yoshimoto
, K.
Umeda
, T.
Iwasa
, Y.
Mizuno
, S.
Fukada
et al, “Generation of transplantable, functional satellite-like cells from mouse embryonic stem cells
,” FASEB J.
23
(6
), 1907
–1919
(2009
).14.
F. S.
Tedesco
, M. F.
Gerli
, L.
Perani
, S.
Benedetti
, F.
Ungaro
, M.
Cassano
et al, “Transplantation of genetically corrected human iPSC-derived progenitors in mice with limb-girdle muscular dystrophy
,” Sci. Transl. Med.
4
(140
), 140ra89
(2012
).15.
J. H.
Lee
, P. A.
Kosinski
, and D. M.
Kemp
, “Contribution of human bone marrow stem cells to individual skeletal myotubes followed by myogenic gene activation
,” Exp. Cell Res.
307
(1
), 174
–182
(2005
).16.
S. V.
Forcales
, “Potential of adipose-derived stem cells in muscular regenerative therapies
,” Front. Aging Neurosci.
7
, 123
(2015
).17.
C. A.
Collins
, I.
Olsen
, P. S.
Zammit
, L.
Heslop
, A.
Petrie
, T. A.
Partridge
et al, “Stem cell function, self-renewal, and behavioral heterogeneity of cells from the adult muscle satellite cell niche
,” Cell
122
(2
), 289
–301
(2005
).18.
D.
Montarras
, J.
Morgan
, C.
Collins
, F.
Relaix
, S.
Zaffran
, A.
Cumano
et al, “Direct isolation of satellite cells for skeletal muscle regeneration
,” Science
309
(5743
), 2064
–2067
(2005
).19.
Z.
Qu-Petersen
, B.
Deasy
, R.
Jankowski
, M.
Ikezawa
, J.
Cummins
, R.
Pruchnic
et al, “Identification of a novel population of muscle stem cells in mice: Potential for muscle regeneration
,” J. Cell Biol.
157
(5
), 851
–864
(2002
).20.
R. O.
Hynes
and A.
Naba
, “Overview of the matrisome—An inventory of extracellular matrix constituents and functions
,” Cold Spring Harbor Perspect. Biol.
4
(1
), a004903
(2012
).21.
K. C.
Clause
and T. H.
Barker
, “Extracellular matrix signaling in morphogenesis and repair
,” Curr. Opin. Biotechnol.
24
(5
), 830
–833
(2013
).22.
T. L.
Adair-Kirk
and R. M.
Senior
, “Fragments of extracellular matrix as mediators of inflammation
,” Int. J. Biochem. Cell Biol.
40
(6–7
), 1101
–1110
(2008
).23.
J. A.
DeQuach
, V.
Mezzano
, A.
Miglani
, S.
Lange
, G. M.
Keller
, F.
Sheikh
et al, “Simple and high yielding method for preparing tissue specific extracellular matrix coatings for cell culture
,” PLoS One
5
(9
), e13039
(2010
).24.
Y.
Zhang
, Y.
He
, S.
Bharadwaj
, N.
Hammam
, K.
Carnagey
, R.
Myers
et al, “Tissue-specific extracellular matrix coatings for the promotion of cell proliferation and maintenance of cell phenotype
,” Biomaterials
30
(23–24
), 4021
–4028
(2009
).25.
R.
Lang
, M. M.
Stern
, L.
Smith
, Y.
Liu
, S.
Bharadwaj
, G.
Liu
et al, “Three-dimensional culture of hepatocytes on porcine liver tissue-derived extracellular matrix
,” Biomaterials
32
(29
), 7042
–7052
(2011
).26.
A.
Skardal
, L.
Smith
, S.
Bharadwaj
, A.
Atala
, S.
Soker
, and Y.
Zhang
, “Tissue specific synthetic ECM hydrogels for 3-D in vitro maintenance of hepatocyte function
,” Biomaterials
33
(18
), 4565
–4575
(2012
).27.
D.
Zhang
, Y.
Zhang
, Y.
Zhang
, H.
Yi
, Z.
Wang
, R.
Wu
et al, “Tissue-specific extracellular matrix enhances skeletal muscle precursor cell expansion and differentiation for potential application in cell therapy
,” Tissue Eng. Part A
23
(15–16
), 784
–794
(2017
).28.
H.
Yi
, S.
Forsythe
, Y.
He
, Q.
Liu
, G.
Xiong
, S.
Wei
et al, “Tissue-specific extracellular matrix promotes myogenic differentiation of human muscle progenitor cells on gelatin and heparin conjugated alginate hydrogels
,” Acta Biomater.
62
, 222
–233
(2017
).29.
X.
Hou
, C.
Shi
, W.
Chen
, B.
Chen
, W.
Jia
, Y.
Guo
et al, “Transplantation of human adipose-derived mesenchymal stem cells on a bladder acellular matrix for bladder regeneration in a canine model
,” Biomed. Mater.
11
(3
), 031001
(2016
).30.
A.
Shokeir
, Y.
Osman
, M.
El-Sherbiny
, M.
Gabr
, T.
Mohsen
, and M.
El-Baz
, “Comparison of partial urethral replacement with acellular matrix versus spontaneous urethral regeneration in a canine model
,” Eur. Urol.
44
(5
), 603
–609
(2003
).31.
A. M.
Kajbafzadeh
, R.
Abbasioun
, S.
Sabetkish
, N.
Sabetkish
, P.
Rahmani
, K.
Tavakkolitabassi
et al, “Future prospects for human tissue engineered urethra transplantation: Decellularization and recellularization-based urethra regeneration
,” Ann. Biomed. Eng.
45
(7
), 1795
–1806
(2017
).32.
A. M.
Kajbafzadeh
, R.
Abbasioun
, N.
Sabetkish
, S.
Sabetkish
, A. A.
Habibi
, and K.
Tavakkolitabassi
, “In vivo human corpus cavernosum regeneration: Fabrication of tissue-engineered corpus cavernosum in rat using the body as a natural bioreactor
,” Int. Urol. Nephrol.
49
(7
), 1193
–1199
(2017
).33.
W.
Dai
, P.
Gerczuk
, Y.
Zhang
, L.
Smith
, O.
Kopyov
, G. L.
Kay
et al, “Intramyocardial injection of heart tissue-derived extracellular matrix improves postinfarction cardiac function in rats
,” J. Cardiovasc. Pharmacol. Ther.
18
(3
), 270
–279
(2013
).34.
S.
Schwarz
, L.
Koerber
, A. F.
Elsaesser
, E.
Goldberg-Bockhorn
, A. M.
Seitz
, L.
Durselen
et al, “Decellularized cartilage matrix as a novel biomatrix for cartilage tissue-engineering applications
,” Tissue Eng. Part A
18
(21–22
), 2195
–2209
(2012
).35.
T. J.
Keane
, A.
DeWard
, R.
Londono
, L. T.
Saldin
, A. A.
Castleton
, L.
Carey
et al, “Tissue-specific effects of esophageal extracellular matrix,” Tissue
Eng. Part A
21
(17–18
), 2293
–2300
(2015
).36.
R. O.
Hynes
, “The extracellular matrix: Not just pretty fibrils
,” Science
326
(5957
), 1216
–1219
(2009
).37.
A.
Urciuolo
, L.
Urbani
, S.
Perin
, P.
Maghsoudlou
, F.
Scottoni
, A.
Gjinovci
et al, “Decellularised skeletal muscles allow functional muscle regeneration by promoting host cell migration
,” Sci. Rep.
8
(1
), 8398
(2018
).38.
S.
Grefte
, M. J. W.
Adjobo-Hermans
, E. M. M.
Versteeg
, W. J. H.
Koopman
, and W. F.
Daamen
, “Impaired primary mouse myotube formation on crosslinked type I collagen films is enhanced by laminin and entactin
,” Acta Biomater.
30
, 265
–276
(2016
).39.
Y.
Ohtake
, H.
Tojo
, and M.
Seiki
, “Multifunctional roles of MT1-MMP in myofiber formation and morphostatic maintenance of skeletal muscle
,” J. Cell Sci.
119
(Pt 18
), 3822
–3832
(2006
).40.
P. M.
Crapo
, T. W.
Gilbert
, and S. F.
Badylak
, “An overview of tissue and whole organ decellularization processes
,” Biomaterials
32
(12
), 3233
–3243
(2011
).41.
T. J.
Keane
, I. T.
Swinehart
, and S. F.
Badylak
, “Methods of tissue decellularization used for preparation of biologic scaffolds and in vivo relevance
,” Methods
84
, 25
–34
(2015
).42.
L.
Gui
, S. A.
Chan
, C. K.
Breuer
, and L. E.
Niklason
, “Novel utilization of serum in tissue decellularization
,” Tissue Eng. Part C Methods
16
(2
), 173
–184
(2010
).43.
V.
Kaartinen
, J. W.
Voncken
, C.
Shuler
, D.
Warburton
, D.
Bu
, N.
Heisterkamp
et al, “Abnormal lung development and cleft palate in mice lacking TGF-beta 3 indicates defects of epithelial-mesenchymal interaction
,” Nat. Genet.
11
(4
), 415
–421
(1995
).44.
S. H.
Lee
and H.
Shin
, “Matrices and scaffolds for delivery of bioactive molecules in bone and cartilage tissue engineering
,” Adv. Drug Delivery Rev.
59
(4–5
), 339
–359
(2007
).45.
H.
Huang
, A. I.
Herrera
, Z.
Luo
, O.
Prakash
, and X. S.
Sun
, “Structural transformation and physical properties of a hydrogel-forming peptide studied by NMR, transmission electron microscopy, and dynamic rheometer
,” Biophys. J.
103
(5
), 979
–988
(2012
).46.
H.
Huang
, Y.
Ding
, X. S.
Sun
, and T. A.
Nguyen
, “Peptide hydrogelation and cell encapsulation for 3D culture of MCF-7 breast cancer cells
,” PloS One
8
(3
), e59482
(2013
).47.
X.
Li
, A.
Galliher-Beckley
, H.
Huang
, X.
Sun
, and J.
Shi
, “Peptide nanofiber hydrogel adjuvanted live virus vaccine enhances cross-protective immunity to porcine reproductive and respiratory syndrome virus
,” Vaccine
31
(41
), 4508
–4515
(2013
).48.
P. G.
Miller
and M. L.
Shuler
, “Design and demonstration of a pumpless 14 compartment microphysiological system
,” Biotechnol. Bioeng.
113
(10
), 2213
–2227
(2016
).49.
J.
Liang
, X. S.
Sun
, Z.
Yang
, and S.
Cao
, “Anticancer drug camptothecin test in 3D hydrogel networks with HeLa cells
,” Sci. Rep.
7
, 37626
(2017
).50.
H.
Huang
, J.
Shi
, J.
Laskin
, Z.
Liu
, D. S.
McVey
, and X. S.
Sun
, “Design of a shear-thinning recoverable peptide hydrogel from native sequences and application for influenza H1N1 vaccine adjuvant
,” Soft Matter
7
(19
), 8905
–8912
(2011
).51.
J.
Liang
, G.
Liu
, J.
Wang
, and X. S.
Sun
, “Controlled release of BSA-linked cisplatin through a PepGel self-assembling peptide nanofiber hydrogel scaffold
,” Amino Acids
49
(12
), 2015
–2021
(2017
).© 2019 Author(s).
2019
Author(s)
You do not currently have access to this content.